Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis

Burns

Volumn 37, Issue 5, 2011, Pages 865-872

  Faezi, Sobhan ^a   Sattari, Morteza ^a   Mahdavi, Mehdi ^b   Roudkenar, Mehryar Habibi ^c  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

Author keywords

Immunisation; Passive; Pseudomonas aeruginosa; Recombinant flagellin

Indexed keywords

FLAGELLIN; OPSONIN; PSEUDOMONAS VACCINE; RECOMBINANT FLAGELLIN TYPE A IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BURN INFECTION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PHAGOCYTOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION;

EID: 79960426751     PISSN: 03054179     EISSN: 18791409     Source Type: Journal    
DOI: 10.1016/j.burns.2010.12.003     Document Type: Article

References (21)

1. A.N. Neely, I.A. Holder, J.P. Wiener-Kronishc, and T. Sawa Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge Burns 31 2005 153 158 (Pubitemid 40430869)
2. I.A. Holder Pseudomonas immunotherapy: a historical overview Vaccine 22 2004 831 839 (Pubitemid 38177383)
3. G. Pier Application of vaccine technology to prevention of Pseudomonas aeruginosa infections Future Drugs Ltd 4 5 2005 645 656 (Pubitemid 41530588)
4. C.R. Hugo, R. Martin, and S. Jean-Claude Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa Trends Microbiol 12 2004 509 517
5. D. Drake, and T.C. Montie Protection against Pseudomonas aeruginosa infection by passive transfer of anti-flagellar serum Can J Microbiol 33 1987 755 763
6. T.R. Anderson, and T.C. Montie Flagellar antibody stimulated opsonophagocytosis of Pseudomonas aeruginosa associated with response to either a- or b-type flagellar antigen Can J Microbiol 35 1989 890 894 (Pubitemid 19264383)
7. S. Navon-Venezia, Y. Barnea, O. Hammer-Munz, and E. Gur Antibodies raised against N′-terminal Pseudomonas aeruginosa flagellin prevent mortality in lethal murine models of infection Int J Mol Med 16 2005 165 171
8. Y. Barnea, Y. Carmeli, L.F. Neville, and H. Kahel-Reifer Therapy with anti-flagellin A monoclonal antibody limits Pseudomonas aeruginosa invasiveness in a mouse burn wound sepsis model Burns 35 2009 390 396
9. S.K. Arora, A.N. Neely, B. Blair, S. Lory, and R. Ramphal Role of motility and flagellin glycosylation in the pathogenesis of Pseudomonas aeruginosa burn wound infections Infect Immun 73 2005 4395 4398 (Pubitemid 40923187)
10. T.C. Montie, D. Doyle-Huntzinger, R.C. Craven, and I.A. Holder Loss of virulence associated with absence of flagellum in an isogenic mutant of Pseudomonas aeruginosa in the burned-mouse model Infect Immun 38 1982 1296 1298 (Pubitemid 13206286)
11. V.L. Campodónico, N.J. Llosa, M. Grout, G. Döring, T. Maira-Litrán, and G.B. Pier Evaluation of flagella versus flagellin of Pseudomonas aeruginosa as vaccines Infect Immun 78 2010 746 755
12. D.D. Stieritz, and I.A. Holder Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model J Infect Dis 131 1975 688 691
13. G.H. Goudarzi, M. Sattari, M.H. Roudkenar, M. Montajabi-Niyat, A. Zavaran-Hosseini, and K. Mosavi-Hosseini Cloning, expression, purification, and characterization of recombinant flagellin isolated from Pseudomonas aeruginosa Biotechnol Lett 31 2009 1353 1360
14. A.N. Neely, I.A. Holder, and G.D. Warden Then and now: studies using a burned mouse model reflect trends in burn research over the past 25 years Burns 25 1999 603 609 (Pubitemid 29440905)
15. I.A. Holder, R. Wheeler, and T.C. Montie Flagellar preparations from Pseudomonas aeruginosa: animal protection studies Infect Immun 35 1982 276 280 (Pubitemid 12200906)
16. M. Allewelt, F.T. Coleman, M. Grout, G.P. Priebe, and G.B. Pier Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread Infect Immun 68 2000 3998 4004 (Pubitemid 30434552)
17. J.M. Scarff, and J.B. Goldberg Vaccination against Pseudomonas aeruginosa pneumonia in immunocompromised mice Clin Vaccine Immunol 15 2008 367 375 (Pubitemid 352025540)
18. P. Ames, D. Desjardins, and G.B. Pier Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide Infect Immun 49 1985 281 285 (Pubitemid 15004853)
19. P.J. Brett, D.C.W. Mah, and D.E. Woods Isolation and characterization of Pseudomonas pseudomallei flagellin proteins Infect Immun 62 5 1994 1914 1919 (Pubitemid 24136996)
20. D.G. Saymen, P. Nathan, I.A. Holder, E.O. Hill, and B.G. Macmillan Infected surface wound: an experimental model and a method for the quantitation of bacteria in infected tissues Appl Microbiol 23 3 1972 509 514
21. T.R. Anderson, and T.C. Montie Opsonophagocytosis of Pseudomonas aeruginosa treated with antiflagellar serum Infect Immun 55 1987 3204 3206 (Pubitemid 18008299)